• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙酰唑胺与高原病

Acetazolamide and high altitude diseases.

作者信息

Bradwell A R, Wright A D, Winterborn M, Imray C

机构信息

Department of Immunology, Medical School, University of Birmingham, England.

出版信息

Int J Sports Med. 1992 Oct;13 Suppl 1:S63-4. doi: 10.1055/s-2007-1024597.

DOI:10.1055/s-2007-1024597
PMID:1483796
Abstract

Acetazolamide is a useful prophylactic for acute mountain sickness causing marked reduction in headache, nausea, vomiting, weakness, etc. Improvements correlate with increased arterial oxygen concentrations, reduction in proteinuria and peripheral oedema and other objective measures of acute mountain sickness. Evidence that Acetazolamide is beneficial for pulmonary oedema or cerebral oedema is scanty because of the lower frequency of these severe forms of mountain sickness. Dexamethasone, used prophylactically, also reduces the symptoms of acute mountain sickness partly due to its euphoric effect. Use of Acetazolamide as a treatment for established acute mountain sickness has been investigated. Large doses of Acetazolamide increase arterial oxygen levels over a few hours and this leads to a reduction of symptoms but data is limited and faster acting carbonic anhydrides inhibitors such as Methazolamide may be preferable in an emergency situation. There is no comparison of the effectiveness of Acetazolamide with other drugs used for treating acute mountain sickness such as steroids and calcium channel blocking drugs. Also, there is no data on drug combinations which could have additive effects and thereby be more beneficial than individual drugs.

摘要

乙酰唑胺是预防急性高原病的有效药物,可显著减轻头痛、恶心、呕吐、乏力等症状。症状的改善与动脉血氧浓度升高、蛋白尿和外周水肿减轻以及急性高原病的其他客观指标相关。由于这些严重形式的高原病发生率较低,关于乙酰唑胺对肺水肿或脑水肿有益的证据不足。预防性使用地塞米松也可部分减轻急性高原病的症状,这部分归因于其欣快效应。已对乙酰唑胺用于治疗已确诊的急性高原病进行了研究。大剂量乙酰唑胺可在数小时内提高动脉血氧水平,从而减轻症状,但数据有限,在紧急情况下,作用更快的碳酸酐酶抑制剂如甲醋唑胺可能更可取。目前尚无乙酰唑胺与用于治疗急性高原病的其他药物(如类固醇和钙通道阻滞剂)疗效的比较。此外,也没有关于可能具有相加作用从而比单一药物更有益的药物组合的数据。

相似文献

1
Acetazolamide and high altitude diseases.乙酰唑胺与高原病
Int J Sports Med. 1992 Oct;13 Suppl 1:S63-4. doi: 10.1055/s-2007-1024597.
2
Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide.急性高山病的药物预防。必须采用相同的上升速率来评估不同剂量乙酰唑胺的有效性。
BMJ. 2001 Jan 6;322(7277):48-9.
3
Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT).银杏叶与乙酰唑胺预防喜马拉雅徒步旅行者急性高原病的随机、双盲、安慰剂对照比较:预防高原病试验(PHAIT)
BMJ. 2004 Apr 3;328(7443):797. doi: 10.1136/bmj.38043.501690.7C. Epub 2004 Mar 11.
4
[Travelling to high altitude areas--acute high altitude sickness].[前往高海拔地区——急性高原病]
Tidsskr Nor Laegeforen. 2002 Jun 30;122(17):1692-4.
5
[Mountaineering and altitude sickness].[登山与高原病]
Ther Umsch. 2001 Jun;58(6):387-93. doi: 10.1024/0040-5930.58.6.387.
6
[High altitude headache: epidemiology, pathophysiology, therapy and prophylaxis].[高原头痛:流行病学、病理生理学、治疗与预防]
Wien Klin Wochenschr. 1999 Oct 29;111(20):830-6.
7
High hopes at high altitudes: pharmacotherapy for acute mountain sickness and high-altitude cerebral and pulmonary oedema.高海拔地区的厚望:急性高原病及高原性脑肺水肿的药物治疗
Expert Opin Pharmacother. 2008 Jan;9(1):119-27. doi: 10.1517/14656566.9.1.119.
8
[Visiting high altitudes--healthy persons and patients with risk diseases].[前往高海拔地区——健康人群和有风险疾病的患者]
MMW Fortschr Med. 2004 Feb 19;146(8):33-4, 36-7.
9
Acetazolamide plus low-dose dexamethasone is better than acetazolamide alone to ameliorate symptoms of acute mountain sickness.乙酰唑胺加小剂量地塞米松在改善急性高原病症状方面比单用乙酰唑胺效果更好。
Aviat Space Environ Med. 1998 Sep;69(9):883-6.
10
[Etiology, clinical aspects and therapy of altitude sickness].[高原病的病因、临床症状及治疗]
Wien Med Wochenschr. 1994;144(7):125-9.

引用本文的文献

1
MM/GBSA prediction of relative binding affinities of carbonic anhydrase inhibitors: effect of atomic charges and comparison with Autodock4.MM/GBSA 预测碳酸酐酶抑制剂的相对结合亲和力:原子电荷的影响及与 Autodock4 的比较。
J Comput Aided Mol Des. 2023 Apr;37(4):167-182. doi: 10.1007/s10822-023-00499-0. Epub 2023 Mar 17.
2
Recent Advances in the Emerging Therapeutic Strategies for Diabetic Kidney Diseases.糖尿病肾病治疗策略的新进展。
Int J Mol Sci. 2022 Sep 17;23(18):10882. doi: 10.3390/ijms231810882.
3
Toward the Discovery of a Novel Class of Leads for High Altitude Disorders by Virtual Screening and Molecular Dynamics Approaches Targeting Carbonic Anhydrase.
通过虚拟筛选和分子动力学方法靶向碳酸酐酶,探索高原疾病新型先导化合物。
Int J Mol Sci. 2022 May 2;23(9):5054. doi: 10.3390/ijms23095054.
4
Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer's Disease and Stroke.碳酸酐酶作为对抗阿尔茨海默病和中风中神经血管单元功能障碍的潜在靶点。
Front Aging Neurosci. 2021 Nov 16;13:772278. doi: 10.3389/fnagi.2021.772278. eCollection 2021.
5
Effects of altitude on mood, behaviour and cognitive functioning. A review.海拔对情绪、行为和认知功能的影响。综述
Sports Med. 1993 Aug;16(2):97-125. doi: 10.2165/00007256-199316020-00003.